744263
Last Update Posted: 2014-10-06
Recruiting has ended
All Genders accepted | 65 Years + |
84496 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
The purpose of this study is to assess the efficacy of 13-valent pneumococcal conjugate vaccine in the prevention of the first episode of vaccine-type pneumococcal community-acquired pneumonia in adults.
Eligibility
Relevant conditions:
Pneumonia, Pneumococcal
Pneumococcal Infections
13-valent Pneumococcal Vaccine
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov